• No results found

Gaucher disease: Current issues in diagnosis and treatment

N/A
N/A
Protected

Academic year: 2021

Share "Gaucher disease: Current issues in diagnosis and treatment"

Copied!
6
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)
(2)
(3)
(4)
(5)
(6)

Referenties

GERELATEERDE DOCUMENTEN

discussed below (see Table 9.), but what is striking is that these shards comprise 7.77% of the total finds of the Archaic and Classical periods. These are therefore the most

The ECA 1997 and the NEMA 2006/10 reports were mostly satisfactory for the identification of impacts (2.2), and the assessment of impact significance (2.5), while all the

Also, significant scientific contributions came from the Institute of Development Studies (IDS) in Sussex – especially from the environmental entitlements group, bringing several

Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden.. Note: To cite this publication please use the final

person with dementia to share this information with their family, making clear that the diagnosis is of importance also to those providing informal care and support. •

Women with high scores on trait anxi- ety had significant lower overall QoL scores on all measurement moments (P < 0.001), irrespective of their diagnosis (benign or breast

Oligosaccharide excretion and severity of disease : Mannose content (measured by gas chromatography and expressed per mmol creatinine) was considered to be a quantitative measure

Aerts JM: Value of plasma chitotriosidase to assess non- neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy. Maegawa GH, Tropak MB,